Prescription Required
Formulation: Extended Release Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Extended Release Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Mirapex ER is a prescription medication used to treat the signs and symptoms of Parkinson’s disease in adults.
It contains pramipexole, an active ingredient that helps improve movement and muscle control by stimulating dopamine receptors in the brain.
Mirapex ER belongs to a class of medications called dopamine agonists. These medications mimic the effects of dopamine, a chemical messenger that helps regulate movement, coordination, and muscle activity.
Parkinson’s disease is a progressive neurological condition that affects the nervous system and causes problems with movement.
It develops when certain nerve cells in the brain become damaged or gradually stop producing enough dopamine.
As dopamine activity decreases, patients may experience tremors, muscle stiffness, slow movement, and difficulty with balance or coordination.
Mirapex ER helps compensate for reduced dopamine activity by stimulating dopamine receptors in the brain.
This can improve movement and reduce certain motor symptoms associated with Parkinson’s disease.
Mirapex ER is an extended-release medication, meaning it gradually releases pramipexole throughout the day.
It is generally taken once daily to provide continuous symptom management.
Although pramipexole is also used to treat restless legs syndrome (RLS), Mirapex ER is not FDA-approved for treating RLS. The immediate-release formulation is approved for moderate to severe primary restless legs syndrome.
Mirapex ER is indicated for the treatment of Parkinson’s disease in adults.
Parkinson’s disease is a long-term neurological disorder that affects how the brain controls movement.
It primarily involves the gradual loss of dopamine-producing nerve cells in an area of the brain called the substantia nigra.
Dopamine is an important chemical messenger that allows nerve cells to communicate with one another.
It helps regulate smooth, controlled movements and supports normal muscle coordination.
When dopamine levels decline, communication between certain brain regions becomes less effective.
This can cause movement difficulties, including tremors, stiffness, slow movements, and problems with balance.
Parkinson’s disease often begins with mild symptoms that gradually become more noticeable over time.
Some patients may first notice a slight tremor in one hand or difficulty performing everyday tasks.
Others may experience muscle stiffness, smaller handwriting, or slower walking.
Mirapex ER helps manage these symptoms by stimulating dopamine receptors.
Although it does not replace damaged nerve cells, it can improve the brain’s response to reduced dopamine activity.
This helps some patients move more easily and perform daily activities with less difficulty.
Mirapex ER treats the symptoms of Parkinson’s disease but does not cure the condition or prevent its progression.
Mirapex ER may help reduce tremors associated with Parkinson’s disease.
A tremor is an involuntary shaking movement that occurs when muscles contract repeatedly.
Parkinson’s tremors commonly begin in one hand or arm.
They may also affect the legs, jaw, or other parts of the body.
These tremors often occur when the affected body part is resting.
For example, a patient’s hand may shake while resting on their lap but become steadier during certain movements.
Tremors can make daily activities more difficult, including holding objects, eating, writing, or getting dressed.
The symptoms develop partly because of changes in the brain circuits responsible for controlling movement.
Reduced dopamine activity disrupts the normal coordination of these circuits.
Mirapex ER helps stimulate dopamine receptors, which may improve movement control and reduce tremor severity.
However, the response varies from person to person.
Some patients experience noticeable improvements, while others continue to have tremors despite treatment.
Mirapex ER may help reduce Parkinson’s-related tremors, but it may not eliminate them completely.
Mirapex ER is used to help manage muscle stiffness associated with Parkinson’s disease.
This symptom is medically known as rigidity.
Rigidity occurs when muscles remain unusually tense, even when a person is trying to relax.
It can affect the arms, legs, neck, shoulders, and other muscle groups.
Patients may experience discomfort, aching, or difficulty moving their joints.
For example, stiffness in the arms may make it harder to button clothing or lift objects.
Stiffness in the legs may make walking and standing more difficult.
Some patients also notice that their movements feel restricted or less natural.
These symptoms occur because changes in dopamine signaling interfere with the brain’s ability to regulate muscle activity.
Mirapex ER helps improve dopamine receptor stimulation, which may reduce muscle rigidity.
As stiffness improves, some patients may find it easier to perform routine movements.
However, the degree of improvement depends on the severity of Parkinson’s disease and the individual’s response to treatment.
Mirapex ER may help reduce muscle stiffness and improve comfort during everyday activities.
Mirapex ER helps manage bradykinesia, one of the main motor symptoms of Parkinson’s disease.
Bradykinesia means that normal movements become slower and more difficult to perform.
Patients may take longer to begin or complete routine activities.
For example, getting out of a chair, walking across a room, or preparing a meal may require more time and effort.
Some patients also experience reduced facial expressions, smaller handwriting, or difficulty making repeated movements.
Walking may become slower, with shorter steps and reduced arm swinging.
Bradykinesia develops because low dopamine activity affects the brain circuits responsible for starting and controlling voluntary movements.
Mirapex ER stimulates dopamine receptors, helping improve signaling within these circuits.
This may allow movements to become smoother and easier to perform.
Some patients may notice improvements in walking speed, hand movements, or the ability to begin certain activities.
By improving dopamine activity, Mirapex ER may help reduce slow movement and support better daily functioning.
Movement Difficulties and Coordination
Parkinson’s disease can affect walking, posture, and coordination.
Some patients may experience difficulty turning, changing direction, or moving through narrow spaces.
Others may develop a shuffling walking pattern, reduced arm movement, or problems maintaining a steady pace.
These symptoms can affect independence and increase the risk of falls.
Mirapex ER helps improve certain movement-related symptoms by stimulating dopamine receptors.
This may make walking and other physical activities easier for some patients.
However, not all balance and coordination problems respond equally well to dopamine agonists.
Balance difficulties may become more noticeable as Parkinson’s disease progresses.
For this reason, medication is often combined with physical therapy, exercise, and other supportive treatments.
Mirapex ER may improve certain movement difficulties, but patients with balance problems should still take precautions to reduce their risk of falling.
Mirapex ER belongs to a class of medications called non-ergot dopamine agonists.
It works by stimulating dopamine receptors in the brain, particularly a group of receptors known as D2-family receptors.
Dopamine is a chemical messenger that helps nerve cells communicate and regulate movement.
In people with Parkinson’s disease, the loss of dopamine-producing nerve cells reduces dopamine activity in areas of the brain responsible for movement.
Mirapex ER helps compensate for this decrease by activating dopamine receptors.
This can improve muscle control and reduce symptoms such as tremors, stiffness, and slow movement.
Mimics the Effects of Dopamine
Mirapex ER works by imitating some of the effects of dopamine in the brain.
It attaches to dopamine receptors and stimulates them, even when natural dopamine levels are low.
This helps improve communication within the brain circuits responsible for controlling movement.
As a result, patients may experience improvements in movement and muscle coordination.
However, Mirapex ER does not restore damaged dopamine-producing nerve cells.
Stimulates Dopamine D2 and D3 Receptors
Pramipexole acts mainly on dopamine receptors belonging to the D2 family, with particularly strong activity at D3 receptors.
These receptors help regulate movement and other neurological functions.
By stimulating these receptors, Mirapex ER helps improve dopamine-related signaling in the brain.
This may reduce certain motor symptoms of Parkinson’s disease, including tremors, muscle rigidity, and bradykinesia.
However, the exact relationship between individual dopamine receptors and symptom improvement is not fully understood.
Provides Extended-Release Medication Delivery
Mirapex ER is formulated to release pramipexole gradually throughout the day.
Unlike immediate-release tablets, which are generally taken several times daily for Parkinson’s disease, Mirapex ER is usually taken once daily.
This extended-release formulation provides continuous medication delivery over the dosing period.
It may help patients maintain symptom control while following a simpler medication schedule.
Mirapex ER helps improve movement by stimulating dopamine receptors, but it does not stop or reverse the progression of Parkinson’s disease.
Yes. Mirapex ER may be prescribed alone or alongside other medications used to treat Parkinson’s disease.
Some patients begin treatment with a dopamine agonist during the earlier stages of the condition.
Others may receive Mirapex ER alongside levodopa when additional symptom control is needed.
Levodopa is a medication that the brain converts into dopamine.
Mirapex ER works differently because it directly stimulates dopamine receptors.
When used together, these medications may provide additional improvement in movement-related symptoms.
However, combining Mirapex ER with levodopa may increase the risk of involuntary movements, called dyskinesia.
Dyskinesia may cause twisting, writhing, or uncontrolled movements of the arms, legs, or other body parts.
Your healthcare provider may need to adjust your medication doses if these symptoms develop.
Do not combine or change Parkinson’s medications without consulting your healthcare provider.
Pramipexole is also used to treat moderate to severe primary restless legs syndrome (RLS).
Restless legs syndrome is a neurological condition that causes an uncomfortable urge to move the legs.
Symptoms commonly develop during periods of rest, particularly in the evening or at night.
People with RLS may experience crawling, tingling, pulling, or aching sensations in their legs.
Moving or stretching the legs may temporarily relieve these symptoms.
Although immediate-release Mirapex is approved for treating moderate to severe primary RLS, Mirapex ER is not FDA-approved for this condition.
The extended-release formulation has different dosing and release characteristics.
Therefore, patients should not automatically switch between the two formulations.
Long-term use of dopamine agonists for RLS can also cause augmentation, a condition in which symptoms begin earlier in the day or become more severe.
For this reason, healthcare providers may consider other treatments, including iron replacement when indicated and certain non-dopaminergic medications.
Do not use Mirapex ER to treat restless legs syndrome unless your healthcare provider specifically recommends an off-label treatment plan.
Mirapex ER begins releasing medication after it is taken, but noticeable improvements in Parkinson’s symptoms may take time.
Some patients may experience improvements in movement, tremors, or muscle stiffness during the first few weeks.
However, the response varies depending on symptom severity, dosage, and individual factors.
Treatment usually begins with a low dose.
Your healthcare provider may gradually increase the dose every five to seven days or longer, depending on your response and tolerance.
This approach helps reduce the risk of side effects while finding an effective dosage.
Because the dose may need gradual adjustment, it can take several weeks to determine how well Mirapex ER controls your symptoms.
Your healthcare provider may monitor changes in tremors, muscle stiffness, walking ability, and daily activities.
Continue taking Mirapex ER as prescribed, even if improvements are gradual. Do not increase your dosage without medical guidance.
Mirapex ER is an extended-release tablet taken by mouth, usually once daily, with or without food.
The tablet must be swallowed whole.
Do not crush, chew, or split Mirapex ER because doing so may interfere with its extended-release properties.
Possible side effects include nausea, dizziness, constipation, sleepiness, swelling of the legs, and hallucinations.
Some patients may experience sudden episodes of falling asleep during daily activities, sometimes without warning.
Mirapex ER may also cause compulsive behaviors, such as uncontrolled gambling, shopping, or eating urges.
Tell your healthcare provider if you or someone close to you notices unusual changes in your behavior.
Patients with kidney problems may require dosage adjustments because pramipexole is primarily removed from the body through the kidneys.
Do not stop taking Mirapex ER suddenly. Abrupt discontinuation may cause withdrawal symptoms or serious complications, including severe muscle stiffness, fever, and confusion.
Your healthcare provider will determine how to reduce the medication gradually if treatment needs to be stopped.
Mirapex ER should be used as part of an individualized Parkinson’s disease treatment plan, with regular follow-up appointments to assess symptom control and medication safety.Â
Mirapex ER is a prescription extended-release medication used to treat the signs and symptoms of Parkinson’s disease in adults.
It contains pramipexole, a dopamine agonist that helps improve movement and muscle control by stimulating dopamine receptors in the brain.
Mirapex ER is usually taken once daily, with or without food.
The extended-release tablet gradually releases medication throughout the day, helping manage symptoms such as tremors, muscle stiffness, and slow movement.
Swallow Mirapex ER tablets whole with water. Do not crush, chew, split, or break the tablets because doing so may interfere with the medication’s extended-release system.
Your healthcare provider will determine the appropriate dosage based on your Parkinson’s symptoms, kidney function, response to treatment, and ability to tolerate the medication.
Treatment usually begins with a low dose, which is gradually increased until adequate symptom control is achieved.
Take Mirapex ER exactly as prescribed. Do not increase your dosage, take extra tablets, or stop treatment without consulting your healthcare provider.
Taking Mirapex ER correctly helps maintain consistent medication delivery and reduces the risk of unwanted side effects.
Mirapex ER should be taken by mouth once daily, preferably at approximately the same time each day.
Follow these steps when taking Mirapex ER:
Mirapex ER provides gradual medication release, allowing pramipexole to act throughout the day.
Taking the medication consistently helps your healthcare provider assess its effectiveness.
Do not crush or divide Mirapex ER tablets, as this may interfere with their extended-release properties.
Mirapex ER is usually taken once daily.
Unlike immediate-release pramipexole tablets, which are commonly taken three times daily for Parkinson’s disease, Mirapex ER is designed to provide medication delivery over an extended period.
This allows patients to follow a simpler daily treatment schedule.
Your healthcare provider will determine the most appropriate time to take the medication.
Some patients may prefer taking Mirapex ER in the morning, while others may follow a different schedule based on their symptoms and treatment needs.
Try to take your medication at approximately the same time each day.
For example, if you normally take Mirapex ER at 8:00 AM, continue taking it around that time unless your healthcare provider recommends a change.
Do not take Mirapex ER more than once daily unless your healthcare provider has specifically prescribed a different regimen.
The recommended dosage of Mirapex ER depends on the severity of Parkinson’s symptoms, kidney function, and response to treatment.
According to U.S. prescribing information, the usual starting dose is 0.375 mg once daily.
Your healthcare provider may gradually increase the dose if additional symptom control is needed.
The first increase is generally to 0.75 mg once daily.
Further increases may be made in increments of 0.75 mg per day, depending on your response and tolerance.
Dosage adjustments should generally occur no more frequently than every five to seven days.
This gradual process is called dose titration.
Dose titration allows your healthcare provider to find a dose that improves symptoms while limiting side effects.
The maximum recommended daily dosage is 4.5 mg.
However, not everyone requires the maximum dose.
Some patients achieve adequate symptom control with lower doses.
Do not increase your Mirapex ER dosage without consulting your healthcare provider, even if your Parkinson’s symptoms remain troublesome.Â
Mirapex ER is usually started at a low dose to reduce the risk of side effects.
Dopamine agonists affect several functions in the brain and nervous system.
When treatment begins, the body may need time to adjust to increased dopamine receptor stimulation.
Some patients experience nausea, dizziness, sleepiness, or low blood pressure during the early stages of treatment.
Starting with a low dose allows your healthcare provider to assess how well you tolerate the medication.
The dose can then be increased gradually if your symptoms remain inadequately controlled.
This approach may reduce the likelihood of severe or persistent side effects.
Your healthcare provider may also consider your age, kidney function, and other medications before increasing the dose.
Follow the recommended dose adjustment schedule and do not increase Mirapex ER more quickly than prescribed.
Yes. Mirapex ER can be taken with or without food.
Eating does not significantly interfere with its overall effectiveness.
However, taking Mirapex ER with a meal may help reduce nausea.
Nausea is a common side effect of dopamine agonists, particularly when treatment begins or the dosage is increased.
Some patients may experience mild stomach discomfort or feel sick after taking the medication.
Taking the tablet with breakfast, lunch, or dinner may make these symptoms easier to manage.
You may also take Mirapex ER on an empty stomach if you tolerate it well.
If nausea continues despite taking the medication with food, contact your healthcare provider.
Your healthcare provider may recommend adjusting your dosage or treatment schedule.
You do not need to take Mirapex ER with food, but taking it with a meal may help reduce nausea and stomach discomfort.
Mirapex ER uses an extended-release system designed to release pramipexole gradually.
This allows the medication to provide dopamine receptor stimulation throughout the day.
Crushing, chewing, or splitting the tablet may interfere with how the medication is released.
This could affect medication delivery and increase the risk of unwanted effects.
For this reason, Mirapex ER tablets must be swallowed whole.
Do not break a tablet to adjust your dosage.
If your prescribed dose changes, your healthcare provider may recommend a different tablet strength.
If you have difficulty swallowing tablets, tell your healthcare provider or pharmacist.
They can discuss whether another medication formulation would be more appropriate.
Never crush, chew, split, or dissolve Mirapex ER tablets unless your healthcare provider confirms an appropriate alternative treatment plan.
Mirapex ER can be taken at a consistent time that fits your daily routine.
There is no single dosing time that is best for everyone.
The appropriate schedule depends on your Parkinson’s symptoms, other medications, and how Mirapex ER affects you.
Some patients prefer morning dosing because it is easier to remember.
Others may benefit from a different schedule recommended by their healthcare provider.
Mirapex ER may cause excessive sleepiness or sudden episodes of falling asleep.
These effects can occur during normal daily activities, sometimes without warning.
Changing the time you take the medication does not necessarily prevent these episodes.
If you experience significant daytime sleepiness, tell your healthcare provider.
Your healthcare provider may review your treatment plan and determine whether adjustments are needed.
Take Mirapex ER at approximately the same time each day and report unusual sleepiness or sudden sleep episodes immediately.
If you forget to take Mirapex ER, the next step depends on how much time has passed since your scheduled dose.
According to the prescribing information, you may take the missed dose if fewer than 12 hours have passed since your usual dosing time.
If more than 12 hours have passed, skip the missed dose.
Take your next dose at the regular scheduled time on the following day.
For example, if you normally take Mirapex ER at 8:00 AM and remember at noon, you may take the missed dose.
However, if you remember after 8:00 PM, skip that dose and continue with your regular schedule the next day.
Do not take two doses at once to make up for a missed dose.
Taking extra medication may increase the risk of nausea, dizziness, excessive sleepiness, and low blood pressure.
If you miss several consecutive doses, contact your healthcare provider before restarting treatment.
You may need to restart at a lower dose and gradually increase it again.Â
Mirapex ER begins releasing medication after you take it, but noticeable improvements in Parkinson’s symptoms may take time.
Some patients may experience improvements in movement, tremors, or muscle stiffness during the first few weeks of treatment.
However, the response varies from person to person.
Your healthcare provider usually starts with a low dose and gradually increases it.
Because the dose is adjusted over time, it may take several weeks to identify the most effective treatment.
The goal is to improve symptoms while minimizing side effects.
Your healthcare provider may monitor your walking ability, muscle stiffness, tremors, and ability to perform daily activities.
Continue taking Mirapex ER consistently, even if you do not notice immediate improvements.
Contact your healthcare provider if your symptoms remain difficult to control.
Some patients taking immediate-release pramipexole may be switched to Mirapex ER.
Both formulations contain the same active ingredient but release it differently.
Immediate-release tablets release medication more quickly and are generally taken several times daily for Parkinson’s disease.
Mirapex ER releases medication gradually and is usually taken once daily.
Patients may sometimes be switched directly to Mirapex ER using the same total daily dose.
However, not everyone responds identically to both formulations.
Your healthcare provider may need to monitor your symptoms and adjust your dosage after the switch.
Do not assume that tablets with the same active ingredient can always be exchanged without medical guidance.
Never switch between immediate-release and extended-release pramipexole tablets without consulting your healthcare provider.
Do not stop taking Mirapex ER simply because your Parkinson’s symptoms have improved.
Mirapex ER helps manage Parkinson’s disease but does not cure the condition.
Your symptoms may improve because the medication is stimulating dopamine receptors effectively.
Stopping treatment may cause tremors, stiffness, or movement difficulties to return.
Suddenly stopping dopamine agonists may also cause withdrawal symptoms.
These can include anxiety, depression, fatigue, sweating, pain, or other uncomfortable symptoms.
In some cases, abrupt withdrawal or rapid dose reduction of Parkinson’s medications may cause serious complications.
These may include severe muscle stiffness, fever, confusion, and changes in consciousness.
Your healthcare provider will recommend a gradual dose reduction if Mirapex ER needs to be discontinued.
Do not suddenly stop taking Mirapex ER or reduce your dosage without medical supervision.
Mirapex ER may cause side effects, particularly during the early stages of treatment or after a dosage increase.
Common side effects include nausea, dizziness, constipation, sleepiness, and swelling of the legs or feet.
Some patients may also experience hallucinations, such as seeing or hearing things that are not present.
Other patients may develop unusual urges or behaviors, including excessive gambling, shopping, eating, or increased sexual urges.
These changes may not always be noticed by the person taking the medication.
Family members or caregivers may notice changes in behavior before the patient does.
Tell your healthcare provider if you develop unusual sleepiness, hallucinations, compulsive behaviors, or significant changes in mood or behavior.
Your healthcare provider may need to adjust your dosage or recommend another treatment.
Seek immediate medical attention if you experience sudden severe confusion, fainting with serious symptoms, or other potentially dangerous reactions.
Mirapex ER is intended for the treatment of Parkinson’s disease in adults.
It should be taken once daily, with or without food, according to your healthcare provider’s instructions.
Do not crush, chew, split, or break the extended-release tablets.
Tell your healthcare provider if you have kidney disease, as reduced kidney function may affect how the medication is removed from your body.
Patients with moderate kidney impairment may require a lower dose or a different initial dosing schedule.
Mirapex ER is not recommended for patients with severe kidney impairment because it has not been adequately studied in this population.
Use caution when standing up quickly because Mirapex ER may cause a sudden drop in blood pressure.
Avoid driving or operating machinery if you experience excessive sleepiness or sudden sleep episodes.
Tell your healthcare provider if you develop hallucinations, unusual behavioral changes, or uncontrollable urges.
Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Do not stop Mirapex ER suddenly, change your dosage without medical advice, or use it more frequently than prescribed.
Continue attending regular follow-up appointments so your healthcare provider can assess your Parkinson’s symptoms, medication response, and potential side effects.
Mirapex ER (Pramipexole) is available in the following forms and strength:
Mirapex ER may cause dizziness, excessive sleepiness, or hallucinations in some patients.
These effects occur because pramipexole stimulates dopamine receptors in the brain, which influence movement, alertness, and other functions.
Some patients may feel unusually tired or dizzy, especially when starting treatment or increasing their dosage.
Hallucinations may cause a person to see, hear, or feel things that are not actually present.
Older adults may be more likely to experience hallucinations while taking Mirapex ER.
These symptoms may interfere with daily activities and increase the risk of accidents or falls.
Avoid driving, operating heavy machinery, or performing activities that require full alertness until you know how Mirapex ER affects you.
Contact your healthcare provider if you experience hallucinations, persistent dizziness, or unusual sleepiness.
Mirapex ER may interact with certain prescription medications, over-the-counter products, and supplements.
Some medications may increase the risk of dizziness, sleepiness, or other side effects when taken with Mirapex ER.
For example, sleeping pills, sedatives, and certain pain medications may increase drowsiness.
Other medications that affect dopamine activity may interfere with the effectiveness of Mirapex ER.
Certain medications may also affect how quickly pramipexole is removed from the body.
This could increase medication exposure and the risk of unwanted effects.
Before starting treatment, tell your healthcare provider about all medications, vitamins, and herbal supplements you currently use.
Do not start, stop, or change the dosage of another medication without consulting your healthcare provider.
Mirapex ER may cause side effects such as nausea, fatigue, constipation, and swelling in the legs or feet.
Nausea is particularly common when treatment begins or the dosage increases.
Taking Mirapex ER with food may help reduce stomach discomfort.
Fatigue may cause unusual tiredness or reduced energy during the day.
Constipation occurs when bowel movements become less frequent or stools become difficult to pass.
Drinking enough fluids, eating fiber-rich foods, and staying physically active when possible may help manage constipation.
Some patients may also develop swelling in the feet, ankles, or lower legs.
This condition is called peripheral edema and occurs when fluid builds up in the tissues.
Mild swelling may develop gradually, but persistent or worsening swelling requires medical evaluation.
Contact your healthcare provider if you experience severe nausea, persistent constipation, unusual fatigue, or increasing swelling in your legs or feet.
Tell your healthcare provider if you have kidney disease or reduced kidney function before starting Mirapex ER.
The kidneys help filter waste products and remove certain medications from the bloodstream.
Pramipexole is primarily eliminated from the body through the kidneys.
When kidney function decreases, the medication may remain in the bloodstream longer than expected.
This can increase the risk of side effects, including dizziness, excessive sleepiness, confusion, and hallucinations.
Your healthcare provider may recommend blood tests to assess kidney function before starting treatment.
Patients with moderate kidney impairment may require a lower dose or a slower dosage adjustment schedule.
Mirapex ER is not recommended for patients with severe kidney impairment because its safety and effectiveness have not been adequately established in this population.
Do not adjust your Mirapex ER dosage on your own if you have kidney problems. Your healthcare provider will determine the appropriate treatment based on your kidney function.
Mirapex ER may cause some patients to fall asleep suddenly during normal daily activities.
These episodes can occur while eating, talking, watching television, or performing other routine tasks.
In serious cases, patients have fallen asleep while driving or operating machinery.
Some people experience warning signs, such as excessive daytime sleepiness.
However, others may fall asleep without feeling noticeably tired beforehand.
This makes sudden sleep episodes particularly dangerous.
The risk may increase when Mirapex ER is combined with alcohol, sleeping pills, or other medications that cause drowsiness.
Tell your healthcare provider if you regularly feel sleepy during the day or have unexpectedly fallen asleep during activities.
Your healthcare provider may need to adjust your medication or recommend another treatment.
Do not drive or participate in potentially dangerous activities if you experience excessive daytime sleepiness or sudden sleep episodes while taking Mirapex ER.
Mirapex ER may cause blood pressure to drop when you stand up from a sitting or lying position.
This condition is called orthostatic hypotension.
Blood pressure normally adjusts when you change positions to maintain adequate blood flow to the brain.
However, Mirapex ER may interfere with this adjustment in some patients.
As a result, standing up quickly may cause dizziness, lightheadedness, blurred vision, or fainting.
These symptoms may be more noticeable when treatment begins or the dosage increases.
To reduce the risk, stand up slowly after sitting or lying down.
If you feel dizzy, sit or lie down until the sensation passes.
Avoid sudden changes in position, especially when getting out of bed.
Your healthcare provider may recommend monitoring your blood pressure if these symptoms occur frequently.
Contact your healthcare provider if you experience repeated dizziness, unusually low blood pressure readings, or fainting while taking Mirapex ER.
Mirapex ER affects dopamine activity in the brain, which is involved in movement, motivation, mood, and behavior.
Some patients may experience changes in mood, thinking, or behavior during treatment.
These may include unusual excitement, irritability, confusion, hallucinations, or changes in emotional responses.
Patients with a history of psychiatric conditions, including depression or bipolar disorder, should tell their healthcare provider before starting Mirapex ER.
Dopamine agonists may worsen certain psychiatric symptoms in susceptible patients.
Mirapex ER may also cause impulse control problems.
These can include unusual urges to gamble, shop excessively, eat compulsively, or engage in sexual activities.
Some patients may not recognize these behavioral changes themselves.
Family members or caregivers may notice changes before the person taking the medication becomes aware of them.
Contact your healthcare provider if you develop unusual mood changes, hallucinations, compulsive behaviors, or other significant changes in thinking or behavior.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant before taking Mirapex ER.
There is limited information about the safety of pramipexole during human pregnancy.
Although animal studies provide some information about potential risks, they cannot fully predict how the medication may affect a developing baby.
Your healthcare provider will consider the severity of your Parkinson’s symptoms, the benefits of treatment, and any potential risks.
Managing Parkinson’s disease during pregnancy may require adjustments to your medication plan.
However, suddenly stopping dopamine agonists can also cause serious problems.
Do not start or stop Mirapex ER during pregnancy without consulting your healthcare provider.
If you become pregnant during treatment, contact your healthcare provider promptly to review your medication plan.
Consult your healthcare provider before using Mirapex ER if you are breastfeeding.
It is not known whether pramipexole passes into human breast milk in clinically significant amounts.
However, pramipexole reduces the release of prolactin, a hormone involved in breast milk production.
As a result, Mirapex ER may reduce milk supply.
There is also limited information about the potential effects of pramipexole exposure on breastfed infants.
Your healthcare provider will consider the importance of Parkinson’s treatment and the potential risks to your baby.
They may recommend an alternative medication or feeding plan depending on your medical needs.
Breastfeeding is generally not recommended during Mirapex ER treatment because of its potential effects on milk production and the uncertainty about infant exposure.
Yes. Mirapex ER may cause changes in mood, emotions, or behavior because it affects dopamine activity in the brain. Dopamine plays an important role in controlling movement, motivation, and emotional responses. Some patients may experience irritability, confusion, hallucinations, or unusual changes in behavior while taking this medication. Patients with a history of mental health conditions, such as depression or bipolar disorder, should inform their healthcare provider before starting treatment. Mirapex ER may worsen certain psychiatric symptoms in susceptible individuals. It may also cause unusual urges, including excessive gambling, shopping, or eating. Contact your healthcare provider if you or someone close to you notices unusual mood changes, compulsive behaviors, hallucinations, or significant changes in personality during treatment.
Mirapex ER is not generally considered an addictive medication in the same way as opioids or other commonly misused drugs. However, it affects dopamine receptors in the brain and can cause changes in behavior or impulse control. Mirapex ER does not replace missing dopamine. Instead, it mimics some of dopamine’s effects by stimulating dopamine receptors. This helps improve movement and muscle control in patients with Parkinson’s disease. Although Mirapex ER is not typically associated with recreational drug use, some patients may develop compulsive behaviors or experience withdrawal symptoms when the medication is reduced or stopped. These withdrawal symptoms may include anxiety, fatigue, depression, sweating, or pain. Do not stop taking Mirapex ER suddenly, even if your Parkinson’s symptoms have improved. Your healthcare provider will recommend a gradual dose reduction if treatment needs to be discontinued.
The time it takes for Mirapex ER to improve Parkinson’s symptoms varies from person to person. Some patients may notice improvements in tremors, muscle stiffness, or movement within the first few days or weeks of treatment. However, others may need several weeks before experiencing noticeable benefits. Mirapex ER is usually started at a low dose to reduce the risk of side effects. Your healthcare provider may gradually increase the dosage until your symptoms are adequately controlled. Because this adjustment takes time, you may not experience the full benefits of treatment immediately. Factors such as the severity of Parkinson’s disease, dosage, kidney function, and individual response can influence how quickly the medication works. Continue taking Mirapex ER as prescribed, even if your symptoms do not improve right away. Contact your healthcare provider if your symptoms remain difficult to manage.
Not necessarily. Whether you need to temporarily stop Mirapex ER before surgery depends on the type of procedure, your medical condition, and your healthcare provider’s instructions. Before undergoing surgery, tell your surgeon, anesthesiologist, and healthcare provider that you are taking Mirapex ER. Certain medications used during surgery may interact with Parkinson’s treatments or increase side effects such as low blood pressure and excessive sleepiness. In many cases, Parkinson’s medications are continued as close to the usual schedule as possible to prevent worsening movement symptoms. However, your healthcare team may recommend adjustments if you cannot swallow medication or if a procedure requires changes to your usual treatment. Do not stop taking Mirapex ER before surgery unless your healthcare provider specifically instructs you to do so. Suddenly stopping the medication may cause severe muscle stiffness, worsening Parkinson’s symptoms, or withdrawal complications.
Mirapex ER is not FDA-approved for treating restless legs syndrome (RLS). However, its active ingredient, pramipexole, is also available in an immediate-release formulation that is approved for moderate to severe primary RLS. Restless legs syndrome is a neurological condition that causes uncomfortable sensations in the legs and a strong urge to move them. Symptoms often become more noticeable during rest, particularly in the evening or at night. The immediate-release formulation may help reduce these symptoms by stimulating dopamine receptors in the brain. However, Mirapex ER is specifically approved for treating the signs and symptoms of Parkinson’s disease. Its extended-release formulation delivers medication gradually throughout the day and should not be automatically substituted for immediate-release pramipexole. Long-term use of dopamine agonists for RLS may also cause augmentation, a condition in which symptoms begin earlier in the day, become more severe, or spread to other parts of the body. Do not use Mirapex ER to treat restless legs syndrome unless your healthcare provider has specifically recommended an off-label treatment plan. Other medications may be more appropriate depending on your symptoms and medical history.
| Generic name: | Pramipexole |
|---|---|
| Formulation: | Extended Release Tablet |
| Strength(s): | 0.75mg, 0.375mg, 1.5mg, 3.75mg, 3mg, 4.5mg |
| Quantities Available: | 30, 90, 180 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Mirapex ER (pramipexole) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Mirapex ER is commonly prescribed in dosages of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 3.75 mg, or 4.5 mg, taken once daily. For a 90-day supply, this means you would order up to 90 tablets (90 days x 1 tablet per day of the prescribed dosage).
Yes, we sell pramipexole on our website. You can enjoy low prices when you order through us. To purchase pramipexole, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Mirapex ER (pramipexole) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Mirapex ER (Pramipexole). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Mirapex ER (Pramipexole).
REVIEWS